Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011, Article ID 313179, 7 pages
http://dx.doi.org/10.4061/2011/313179
Review Article

Adiponectin Provides Cardiovascular Protection in Metabolic Syndrome

Department of Bioregulation, Nippon Medical School, 1-396 Kosugi-machi, Nakahara-ku, Kawasaki, Kanagawa 211-8533, Japan

Received 24 November 2010; Accepted 19 December 2010

Academic Editor: Rei Shibata

Copyright © 2011 Yoshihisa Okamoto. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Okamoto, S. Kihara, T. Funahashi, Y. Matsuzawa, and P. Libby, “Adiponectin: a key adipocytokine in metabolic syndrome,” Clinical Science, vol. 110, no. 3, pp. 267–278, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. Y. Arita, S. Kihara, and S. Kihara, “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Hotta, T. Funahashi, N. L. Bodkin, H. K. Ortmeyer, Y. Arita, B. C. Hansen, and Y. Matsuzawa, “Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys,” Diabetes, vol. 50, no. 5, pp. 1126–1133, 2001. View at Google Scholar · View at Scopus
  4. Y. Iwashima, T. Katsuya, and T. Katsuya, “Hypoadiponectinemia is an independent risk factor for hypertension,” Hypertension, vol. 43, no. 6, pp. 1318–1323, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Matsubara, S. Maruoka, and S. Katayose, “Decreased plasma adiponectin concentrations in women with dyslipidemia,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 6, pp. 2764–2769, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Ouchi, S. Kihara, and S. Kihara, “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin,” Circulation, vol. 100, no. 25, pp. 2473–2476, 1999. View at Google Scholar · View at Scopus
  7. M. Kumada, S. Kihara, and S. Kihara, “Association of hypoadiponectinemia with coronary artery disease in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 1, pp. 85–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Pischon, C. J. Girman, G. S. Hotamisligil, N. Rifai, F. B. Hu, and E. B. Rimm, “Plasma adiponectin levels and risk of myocardial infarction in men,” Journal of the American Medical Association, vol. 291, no. 14, pp. 1730–1737, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. F. Otsuka, S. Sugiyama, and S. Sugiyama, “Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease,” Journal of the American College of Cardiology, vol. 48, no. 6, pp. 1155–1162, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. Y. Kitta, H. Takano, and H. Takano, “Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries,” International Journal of Cardiology, vol. 131, no. 1, pp. 78–82, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. E. Moldoveanu, B. Mut-Vitcu, and B. Mut-Vitcu, “Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase,” Clinical Biochemistry, vol. 41, no. 18, pp. 1429–1433, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. N. Komura, S. Kihara, and S. Kihara, “Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease,” Circulation Journal, vol. 72, no. 1, pp. 23–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Hong, C. G. Park, H. S. Seo, D. J. Oh, and Y. M. Ro, “Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index,” Blood Pressure, vol. 13, no. 4, pp. 236–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Mitsuhashi, H. Yatsuya, and H. Yatsuya, “Adiponectin level and left ventricular hypertrophy in Japanese men,” Hypertension, vol. 49, no. 6, pp. 1448–1454, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Kozakova, E. Muscelli, A. Flyvbjerg, J. Frystyk, C. Morizzo, C. Palombo, and E. Ferrannini, “Adiponectin and left ventricular structure and function in healthy adults,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2811–2818, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. C. Kistorp, J. Faber, S. Galatius, F. Gustafsson, J. Frystyk, A. Flyvbjerg, and P. Hildebrandt, “Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure,” Circulation, vol. 112, no. 12, pp. 1756–1762, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. T. Nakamura, H. Funayama, and H. Funayama, “Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure,” Circulation Journal, vol. 70, no. 12, pp. 1557–1562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Tamura, Y. Furukawa, and Y. Furukawa, “Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure,” Circulation Journal, vol. 71, no. 5, pp. 623–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Shibata, Y. Izumiya, and Y. Izumiya, “Adiponectin protects against the development of systolic dysfunction following myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 6, pp. 1065–1074, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. Biolo, R. Shibata, N. Ouchi, S. Kihara, M. Sonoda, K. Walsh, and F. Sam, “Determinants of adiponectin levels in patients with chronic systolic heart failure,” American Journal of Cardiology, vol. 105, no. 8, pp. 1147–1152, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. N. Komura, S. Kihara, M. Sonoda, N. Maeda, Y. Tochino, T. Funahashi, and I. Shimomura, “Increment and impairment of adiponectin in renal failure,” Cardiovascular Research, vol. 86, no. 3, pp. 471–477, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. Zoccali, F. Mallamaci, and F. Mallamaci, “Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 134–141, 2002. View at Google Scholar · View at Scopus
  23. Y. Iwashima, T. Horio, and T. Horio, “Adiponectin and renal function, and implication as a risk of cardiovascular disease,” American Journal of Cardiology, vol. 98, no. 12, pp. 1603–1608, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. J. Díez, P. Estrada, and P. Estrada, “High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients,” American Journal of Nephrology, vol. 30, no. 3, pp. 244–252, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. V. Menon, L. Li, and L. Li, “Adiponectin and mortality in patients with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 9, pp. 2599–2606, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. Y. Okamoto, Y. Arita, and Y. Arita, “An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls,” Hormone and Metabolic Research, vol. 32, no. 2, pp. 47–50, 2000. View at Google Scholar · View at Scopus
  27. P. Libby, Y. Okamoto, V. Z. Rocha, and E. Folco, “Inflammation in atherosclerosis: transition from theory to practice,” Circulation Journal, vol. 74, no. 2, pp. 213–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Ouchi, S. Kihara, and S. Kihara, “Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway,” Circulation, vol. 102, no. 11, pp. 1296–1301, 2000. View at Google Scholar · View at Scopus
  29. C. Kobashi, M. Urakaze, and M. Urakaze, “Adiponectin inhibits endothelial synthesis of interleukin-8,” Circulation Research, vol. 97, no. 12, pp. 1245–1252, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. R. Ouedraogo, Y. Gong, and Y. Gong, “Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo,” Journal of Clinical Investigation, vol. 117, no. 6, pp. 1718–1726, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. K. Tsubakio-Yamamoto, F. Matsuura, and F. Matsuura, “Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages,” Biochemical and Biophysical Research Communications, vol. 375, no. 3, pp. 390–394, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. T. Yokota, K. Oritani, and K. Oritani, “Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages,” Blood, vol. 96, no. 5, pp. 1723–1732, 2000. View at Google Scholar · View at Scopus
  33. Y. Okamoto, E. J. Folco, and E. J. Folco, “Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis,” Circulation Research, vol. 102, no. 2, pp. 218–225, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. Kumada, S. Kihara, and S. Kihara, “Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages,” Circulation, vol. 109, no. 17, pp. 2046–2049, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. Y. Arita, S. Kihara, and S. Kihara, “Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell,” Circulation, vol. 105, no. 24, pp. 2893–2898, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Okamoto, S. Kihara, and S. Kihara, “Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 106, no. 22, pp. 2767–2770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Yamauchi, J. Kamon, and J. Kamon, “Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis,” Journal of Biological Chemistry, vol. 278, no. 4, pp. 2461–2468, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. Matsuda, I. Shimomura, and I. Shimomura, “Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis,” Journal of Biological Chemistry, vol. 277, no. 40, pp. 37487–37491, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. Shibata, N. Ouchi, and N. Ouchi, “Adiponectin-mediated modulation of hypertrophic signals in the heart,” Nature Medicine, vol. 10, no. 12, pp. 1384–1389, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. R. Shibata, K. Sato, and K. Sato, “Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms,” Nature Medicine, vol. 11, no. 10, pp. 1096–1103, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. L. Tao, E. Gao, and E. Gao, “Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress,” Circulation, vol. 115, no. 11, pp. 1408–1416, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. K. Fujita, N. Maeda, and N. Maeda, “Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-α,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 863–870, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. G. Hansmann, R. A. Wagner, and R. A. Wagner, “Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation,” Circulation, vol. 115, no. 10, pp. 1275–1284, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. B. D. Medoff, Y. Okamoto, and Y. Okamoto, “Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 4, pp. 397–406, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. Y. Nakagawa, K. Kishida, S. Kihara, T. Funahashi, and I. Shimomura, “Adiponectin ameliorates hypoxia-induced pulmonary arterial remodeling,” Biochemical and Biophysical Research Communications, vol. 382, no. 1, pp. 183–188, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh, “Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling,” Journal of Biological Chemistry, vol. 279, no. 27, pp. 28670–28674, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. N. Ouchi, H. Kobayashi, and H. Kobayashi, “Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells,” Journal of Biological Chemistry, vol. 279, no. 2, pp. 1304–1309, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. H. Kobayashi, N. Ouchi, and N. Ouchi, “Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin,” Circulation research, vol. 94, no. 4, pp. e27–e31, 2004. View at Google Scholar · View at Scopus
  49. R. Shibata, C. Skurk, and C. Skurk, “Adiponectin promotes endothelial progenitor cell number and function,” FEBS Letters, vol. 582, no. 11, pp. 1607–1612, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. Chang, Y. Li, and Y. Li, “Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway,” Diabetes, vol. 59, no. 11, pp. 2949–2959, 2010. View at Publisher · View at Google Scholar · View at PubMed
  51. N. Ouchi, M. Ohishi, and M. Ohishi, “Association of hypoadiponectinemia with impaired vasoreactivity,” Hypertension, vol. 42, no. 3, pp. 231–234, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. K. Ohashi, S. Kihara, and S. Kihara, “Adiponectin replenishment ameliorates obesity-related hypertension,” Hypertension, vol. 47, no. 6, pp. 1108–1116, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. A. Kurata, H. Nishizawa, and H. Nishizawa, “Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation,” Kidney International, vol. 70, no. 10, pp. 1717–1724, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon, “Adiponectin stimulates production of nitric oxide in vascular endothelial cells,” Journal of Biological Chemistry, vol. 278, no. 45, pp. 45021–45026, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. K. K. Y. Cheng, K. S. L. Lam, and K. S. L. Lam, “Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells,” Diabetes, vol. 56, no. 5, pp. 1387–1394, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. N. Maeda, M. Takahashi, and M. Takahashi, “PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein,” Diabetes, vol. 50, no. 9, pp. 2094–2099, 2001. View at Google Scholar · View at Scopus
  57. A. Higuchi, K. Ohashi, R. Shibata, S. Sono-Romanelli, K. Walsh, and N. Ouchi, “Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 1, pp. 46–53, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. A. Hiuge, A. Tenenbaum, and A. Tenenbaum, “Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 635–641, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. N. Komiya, H. Hirose, H. Kawabe, H. Itoh, and I. Saito, “Effects of telmisartan therapy on metabolic profiles and serum high molecular weight (HMW)-adiponectin level in Japanese male hypertensive subjects with abdominal obesity,” Journal of Atherosclerosis and Thrombosis, vol. 16, no. 2, pp. 137–142, 2009. View at Google Scholar · View at Scopus
  60. P. Li, R. Shibata, S. Maruyama, M. Kondo, K. Ohashi, N. Ouchi, and T. Murohara, “Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway,” American Journal of Physiology, vol. 299, no. 4, pp. E560–E566, 2010. View at Publisher · View at Google Scholar · View at PubMed
  61. T. Takagi, M. Matsuda, and M. Matsuda, “Effect of pravastatin on the development of diabetes and adiponectin production,” Atherosclerosis, vol. 196, no. 1, pp. 114–121, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. N. Inami, S. Nomura, and S. Nomura, “Effects of pitavastatin on adiponectin in patients with hyperlipidemia,” Pathophysiology of Haemostasis and Thrombosis, vol. 36, no. 1, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. O. Tsukamoto, M. Fujita, and M. Fujita, “Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure,” Journal of the American College of Cardiology, vol. 53, no. 22, pp. 2070–2077, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. K. Kondo, R. Shibata, and R. Shibata, “Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model,” Circulation: Cardiovascular Interventions, vol. 3, no. 2, pp. 166–173, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. T. Yamauchi, Y. Nio, and Y. Nio, “Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions,” Nature Medicine, vol. 13, no. 3, pp. 332–339, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. C. Hug, J. Wang, N. S. Ahmad, J. S. Bogan, T. S. Tsao, and H. F. Lodish, “T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 28, pp. 10308–10313, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. Y. Takemura, N. Ouchi, and N. Ouchi, “Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies,” Journal of Clinical Investigation, vol. 117, no. 2, pp. 375–386, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. M. S. Denzel, M.-C. Scimia, P. M. Zumstein, K. Walsh, P. Ruiz-Lozano, and B. Ranscht, “T-cadherin is critical for adiponectin-mediated cardioprotection in mice,” Journal of Clinical Investigation, vol. 120, no. 12, pp. 4342–4352, 2010. View at Publisher · View at Google Scholar · View at PubMed